Can mean platelet volume values predict maternal and fetal outcomes in the third trimester of pregnancy in gestational diabetic patients? A retrospective cohort study
Authors:
- Asiye UzunAUAsiye Uzun
- Guzin Zeren OzturkGOGuzin Zeren Ozturk
- Adeviye Elci AtilganAAAdeviye Elci Atilgan
- Saliha Busra AksuSASaliha Busra Aksu
- Ismail BiyikIBIsmail Biyik
Open Access
- 1 January 2025
- journal article
- Published by ScopeMed in Medicine Science | International Medical Journal
- Vol. 14 (1) , 224
Abstract
This study aims to determine if mean platelet volume (MPV) can predict maternal and fetal outcomes in pregnant women during their third trimester. A retrospective case-control study was conducted at Medipol Hospital's Obstetrics and Gynecology Clinic, involving 200 women with gestational diabetes mellitus (GDM) and 200 healthy pregnant women. Data collected included age, gestational age, body mass index (BMI), and complete blood count parameters such as hemoglobin, hematocrit, thrombocyte count, and MPV values. The results indicated that the GDM group had significantly higher age, BMI, cesarean rates, and MPV values compared to the healthy group. Maternal complications like preeclampsia, preterm labor, shoulder dystocia, and fetal growth restriction were more frequent in the GDM group. Neonatal complications, including hyperbilirubinemia, hypoglycemia, transient tachypnea of the newborn (TTN), and increased admissions to the neonatal intensive care unit, were also significantly higher. A notable finding was the significant association between elevated maternal MPV values and the occurrence of TTN in newborns (p=0.043). Mothers of infants with TTN had higher third-trimester MPV values. Receiver operating characteristic (ROC) curve analysis established a cut-off MPV value of >11.35 ft for predicting TTN. The study concludes that elevated MPV in women with GDM is strongly associated with an increased risk of TTN in their newborns. MPV, being a simple and cost-effective parameter obtained from routine blood counts, could serve as a predictive marker for TTN. However, due to limitations such as the retrospective design and single-center data, further multi-center cohort studies are recommended to validate these findings and establish MPV as a reliable predictor for adverse neonatal outcomes in GDM pregnancies.Keywords
This publication has 25 references indexed in Scilit:
- Mean Platelet Volume Predicts Severe COVID-19 IllnessSeminars in Thrombosis and Hemostasis, 2021
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and preventionInternational Journal of Gynecology & Obstetrics, 2019
- Gestational Diabetes Mellitus: Mechanisms, Treatment, and ComplicationsTrends in Endocrinology & Metabolism, 2018
- Impact of type 1 diabetes on maternal long-term risk of hospitalisation and mortality: a nationwide combined clinical and register-based cohort study (The EPICOM study)Diabetologia, 2018
- Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: a Systematic Review and Meta-analysisCurrent Diabetes Reports, 2017
- Placental maternal vascular malperfusion and adverse pregnancy outcomes in gestational diabetes mellitusPlacenta, 2017
- Current trends in the diagnosis and management of gestational diabetes mellitus in the United States*The Journal of Maternal-Fetal & Neonatal Medicine, 2016
- Strategies for managing transient tachypnoea of the newborn - a systematic reviewThe Journal of Maternal-Fetal & Neonatal Medicine, 2016
- The association between mean platelet volume and cardiovascular risk factorsEuropean Journal of Internal Medicine, 2016
- Global estimates of the prevalence of hyperglycaemia in pregnancyDiabetes Research and Clinical Practice, 2014